Zweig-DiMenna Associates’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
SL
Zweig-DiMenna Associates's RLAY Position: Q3 2026 in Review
Zweig-DiMenna Associates opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 309,700 shares worth $5.59M. The stake represents 0.43% of the portfolio and ranks #65 among its holdings.
188 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Zweig-DiMenna Associates held 309,700 shares of Relay Therapeutics worth $5.59M as of Q3 2026.
- Relay Therapeutics was a new Zweig-DiMenna Associates position in Q3 2026.
- Relay Therapeutics made up 0.43% of Zweig-DiMenna Associates's portfolio in Q3 2026, its #65 holding.
- 188 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Zweig-DiMenna Associates's 13F filing for Q3 2026, filed 6 Nov 2026.